Hazards in determining whether a drug is hazardous

Area of Science:

• Occupational Health
• Pharmaceutical Sciences
• Drug Safety

Background:

• The US National Institute for Occupational Safety and Health (NIOSH) provides foundational criteria for identifying hazardous drugs.
• Existing NIOSH guidelines require supplementary principles for practical organizational implementation.
• Challenges exist in standardizing the evaluation and handling of hazardous medications in healthcare settings.

Purpose of the Study:

• To develop enhanced guiding principles for identifying and managing hazardous formulary drugs within an organization.
• To create a systematic and streamlined process for evaluating drug hazardousness and handling requirements.
• To explore the utility of a tiered classification system for hazardous drugs.

Main Methods:

• Developed distinct directives for assessing inherent drug toxicity and defining safe handling based on dosage form exposure risks.
• Established a systematic approach to determine the scope of drugs for NIOSH review.
• Streamlined the internal drug evaluation process by defining specific criteria for organizational review.
• Analyzed the advantages and disadvantages of a tiered hazardous drug classification system.

Main Results:

• Separate directives were created for drug toxicity assessment and safe handling protocols.
• A systematic method was implemented to define the scope of NIOSH-evaluated drugs.
• The organizational drug review process was streamlined for efficiency.
• Consideration was given to a tiered classification system for hazardous drugs.

Conclusions:

• The developed principles facilitate the feasible adoption of hazardous drug management at the organizational level.
• A systematic and streamlined review process enhances the identification and management of hazardous drugs.
• A tiered classification system offers potential benefits for hazardous drug management beyond NIOSH recommendations.